Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11130995 Simultaneous determination of aneuploidy and fetal fraction

Patent 11130995 was granted and assigned to Verinata Health on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Verinata Health
0
Date Filed
July 31, 2017
0
Date of Patent
September 28, 2021
0
Patent Applicant
‌
Verinata Health
0
Patent Application Number
20170731
0
Patent Citations Received
‌
US Patent 12110552 Methods for simultaneous amplification of target loci
0
‌
US Patent 11447820 Methods and compositions for determining ploidy
‌
US Patent 11939634 Methods for simultaneous amplification of target loci
0
‌
US Patent 11946101 Methods and compositions for determining ploidy
0
‌
US Patent 12020778 Methods for non-invasive prenatal ploidy calling
0
‌
US Patent 12024738 Methods for cancer detection and monitoring
0
‌
US Patent 12084720 Assessing graft suitability for transplantation
0
‌
US Patent 11459615 Methods for simultaneous amplification of target loci
‌
US Patent 11479812 Methods and compositions for determining ploidy
‌
US Patent 11482300 Methods for preparing a DNA fraction from a biological sample for analyzing genotypes of cell-free DNA
•••
Patent Inventor Names
David A Comstock
0
Manjula Chinnappa
0
Richard P Rava
0
Stephen Quake
0
Gabrielle Heilek
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11130995
0

Find more entities like US Patent 11130995 Simultaneous determination of aneuploidy and fetal fraction

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.